BridgeMD
New treatment option for Hip Fractures (ICD-10 72.01-72.2)
Official title Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
ClinicalTrials.gov ID: NCT07189260
What this study is testing
- What it's testing
- The goal of this clinical trial is to investigate whether pre- and postoperative treatment with systematic PEP therapy can prevent hospital-acquired pneumonia in patients with hip frac-ture. It will also learn about the barriers regarding PEP therapy in this group of patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Hip fracture regardless of age
- Cognitively well-functioning
- Able to understand the study and give informed consent
- Able to speak and understand Danish
- Resident of Region Hovedstaden or Region Sjælland
You likely can't join if
- Cognitively impaired
- Unable to understand the study and give informed consent
- Pneumonia upon admission
- Delirium upon admission
- Pneumothorax For patients with e.g. dementia or brain injury, the ability to give informed consent will be assessed individually.
The study team makes the final eligibility decision.
Where it's taking place
- Copenhagen, Denmark
- Herlev, Denmark
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Copenhagen, Denmark; Herlev, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.